TY - STD TI - Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019. https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.6-FINAL-08Nov2018-wms.pdf. UR - https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.6-FINAL-08Nov2018-wms.pdf ID - ref1 ER - TY - JOUR AU - Wedzicha, J. A. PY - 2016 DA - 2016// TI - Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD JO - N Engl J Med VL - 374 UR - https://doi.org/10.1056/NEJMoa1516385 DO - 10.1056/NEJMoa1516385 ID - Wedzicha2016 ER - TY - JOUR AU - Papi, A. PY - 2018 DA - 2018// TI - Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial JO - Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30206-X DO - 10.1016/S0140-6736(18)30206-X ID - Papi2018 ER - TY - JOUR AU - Rodrigo, G. J. PY - 2017 DA - 2017// TI - LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis JO - Int J Chron Obstruct Pulmon Dis VL - 12 UR - https://doi.org/10.2147/COPD.S130482 DO - 10.2147/COPD.S130482 ID - Rodrigo2017 ER - TY - JOUR AU - DiSantostefano, R. L. PY - 2014 DA - 2014// TI - Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study JO - PLoS ONE VL - 9 UR - https://doi.org/10.1371/journal.pone.0097149 DO - 10.1371/journal.pone.0097149 ID - DiSantostefano2014 ER - TY - JOUR AU - Singh, S. AU - Amin, A. V. AU - Loke, Y. K. PY - 2009 DA - 2009// TI - Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis JO - Arch Intern Med VL - 169 UR - https://doi.org/10.1001/archinternmed.2008.550 DO - 10.1001/archinternmed.2008.550 ID - Singh2009 ER - TY - JOUR AU - Siddiqui, S. H. PY - 2015 DA - 2015// TI - Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease JO - Am J RespirCrit Care Med VL - 192 UR - https://doi.org/10.1164/rccm.201502-0235LE DO - 10.1164/rccm.201502-0235LE ID - Siddiqui2015 ER - TY - JOUR AU - Yun, J. H. PY - 2018 DA - 2018// TI - Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease JO - J Allergy ClinImmunol VL - 141 UR - https://doi.org/10.1016/j.jaci.2018.04.010 DO - 10.1016/j.jaci.2018.04.010 ID - Yun2018 ER - TY - JOUR AU - Pascoe, S. PY - 2015 DA - 2015// TI - Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials JO - Lancet Respir Med VL - 3 UR - https://doi.org/10.1016/S2213-2600(15)00106-X DO - 10.1016/S2213-2600(15)00106-X ID - Pascoe2015 ER - TY - JOUR AU - Watz, H. PY - 2016 DA - 2016// TI - Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial JO - Lancet Respir Med VL - 4 UR - https://doi.org/10.1016/S2213-2600(16)00100-4 DO - 10.1016/S2213-2600(16)00100-4 ID - Watz2016 ER - TY - JOUR AU - Bafadhel, M. PY - 2018 DA - 2018// TI - Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials JO - Lancet Respir Med VL - 6 UR - https://doi.org/10.1016/S2213-2600(18)30006-7 DO - 10.1016/S2213-2600(18)30006-7 ID - Bafadhel2018 ER - TY - JOUR AU - Pavord, I. D. PY - 2016 DA - 2016// TI - Blood eosinophils and inhaled corticosteroid/long-acting beta-2 agonist efficacy in COPD JO - Thorax VL - 71 UR - https://doi.org/10.1136/thoraxjnl-2015-207021 DO - 10.1136/thoraxjnl-2015-207021 ID - Pavord2016 ER - TY - JOUR AU - Savran, O. PY - 2019 DA - 2019// TI - COPD patients prescribed inhaled corticosteroid in general practice: Based on disease characteristics according to guidelines? JO - ChronRespir Dis VL - 16 ID - Savran2019 ER - TY - STD TI - Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020. https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0wms.pdf. UR - https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0wms.pdf ID - ref14 ER - TY - STD TI - Recommendations on de-escalation of ICS treatment on COPD patients. https://www.lungemedicin.dk/fagligt/299-kol-behandling.html. UR - https://www.lungemedicin.dk/fagligt/299-kol-behandling.html ID - ref15 ER - TY - JOUR AU - Casanova, C. PY - 2017 DA - 2017// TI - Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD JO - EurRespir J VL - 50 ID - Casanova2017 ER - TY - JOUR AU - Suissa, S. AU - Dell'Aniello, S. AU - Ernst, P. PY - 2018 DA - 2018// TI - Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study JO - Lancet Respir Med VL - 6 UR - https://doi.org/10.1016/S2213-2600(18)30368-0 DO - 10.1016/S2213-2600(18)30368-0 ID - Suissa2018 ER -